We are live on
!
Find out more
SR
Summer Road Portfolio holdings
AUM
$142M
1-Year Est. Return
43.61%
This Fund
S&P 500
This Quarter
Est. Return
+104.04%
1 Year Est. Return
+43.61%
3 Year Est. Return
+101.14%
5 Year Est. Return
-35.41%
10 Year Est. Return
+349.33%
AUM
$131M
AUM Growth
+$96.5M
(+282%)
Cap. Flow
+$47.6M
Cap. Flow
% of AUM
36.39%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ocular Therapeutix
OCUL
|
+$47.6M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ocular Therapeutix
OCUL
$1.96B
| $131M | 100% |
14,360,633
+6,700,083
| +87% | +$47.6M |
|
Similar funds
EC
TA
AC
ACP
PC
YEPX
ALM
BRIA
Summer Road's Q1 2024 Portfolio in Review
As of Q1 2024, Summer Road held 1 position worth $131M, up 282% from $34.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Summer Road deployed $47.6M of net new capital in Q1 2024, adding to 1 existing holding.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Summer Road added most to Ocular Therapeutix in Q1 2024, an estimated $47.6M increase.
- Summer Road's ten largest holdings make up 100% of its $131M portfolio in Q1 2024.
- Summer Road opened 0 new positions and closed 0 in Q1 2024.
- Summer Road's portfolio value rose 282% quarter-over-quarter to $131M.
Based on Summer Road's 13F filing for Q1 2024, filed 15 May 2024.